Literature DB >> 29960150

Synthesis and biological characterization of organoruthenium complexes with 8-hydroxyquinolines.

Jakob Kljun1, Ignacio E León2, Špela Peršič1, Juan F Cadavid-Vargas2, Susana B Etcheverry3, Weijiang He4, Yang Bai4, Iztok Turel5.   

Abstract

In this study we report the synthesis, characterization and a thorough biological evaluation of twelve organoruthenium-8-hydroxyquinolinato (Ru-hq) complexes. The chosen hqH ligands bear various halogen atoms in different positions which enables to study effect of the substituents on physico-chemical and biological properties. The determined crystal structures of novel complexes expectedly show the cymene ring, a bidentately coordinated deprotonated hq and a halide ligand (chlorido or iodido) coordinated to the ruthenium central ion. In previous studies the anticancer potential of organoruthenium complex with 8-hydroxyquinoline ligand clioquinol was well established and we have decided to perform an extended biological evaluation (antibacterial and antitumor activity) of the whole series of halo-substituted analogs. Beside the cytotoxic potential of studied compounds also the effect of two selected complexes (9 and 10) on apoptosis induction in MG-63 and A549 cells was also studied via externalization of phosphatidylserine at the outer plasma membrane leaflet. Both selected complexes that gave best preliminary cytotoxicity results contain bromo substituted hq ligands. Apoptosis induction results are in agreement with the cell viability assays suggesting the higher and more selective anticancer activity of complex 10 in comparison to complex 9 on MG-63 cells.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29960150     DOI: 10.1016/j.jinorgbio.2018.05.009

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  6 in total

1.  Synthesis, Characterisation and In Vitro Anticancer Activity of Catalytically Active Indole-Based Half-Sandwich Complexes.

Authors:  Joan J Soldevila-Barreda; Kehinde B Fawibe; Maria Azmanova; Laia Rafols; Anaïs Pitto-Barry; Uche B Eke; Nicolas P E Barry
Journal:  Molecules       Date:  2020-10-03       Impact factor: 4.411

2.  Novel Papaverine Metal Complexes with Potential Anticancer Activities.

Authors:  Ahmed Gaber; Walaa F Alsanie; Deo Nandan Kumar; Moamen S Refat; Essa M Saied
Journal:  Molecules       Date:  2020-11-20       Impact factor: 4.411

3.  Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line.

Authors:  Jakob Kljun; Renata Pavlič; Eva Hafner; Tanja Lipec; Sara Moreno-Da Silva; Primož Tič; Iztok Turel; Tomaž Büdefeld; Jure Stojan; Tea Lanišnik Rižner
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

4.  Systematic Study on the Cytotoxic Potency of Commonly Used Dimeric Metal Precursors in Human Cancer Cell Lines.

Authors:  Heiko Geisler; Sophia Harringer; Dominik Wenisch; Richard Urban; Michael A Jakupec; Wolfgang Kandioller; Bernhard K Keppler
Journal:  ChemistryOpen       Date:  2022-02-24       Impact factor: 2.630

5.  A new palladium-based antiproliferative agent: synthesis, characterization, computational calculations, cytotoxicity, and DNA binding properties.

Authors:  Mohammad Aminzadeh; Hassan Mansouri-Torshizi; Roghayeh Aleeshah; Khatereh Abdi; Maryam Saeidifar
Journal:  Biometals       Date:  2021-08-07       Impact factor: 2.949

6.  Comparison of Solution Chemical Properties and Biological Activity of Ruthenium Complexes of Selected β-Diketone, 8-Hydroxyquinoline and Pyrithione Ligands.

Authors:  Tamás Pivarcsik; Gábor Tóth; Nikoletta Szemerédi; Anita Bogdanov; Gabriella Spengler; Jakob Kljun; Jerneja Kladnik; Iztok Turel; Éva A Enyedy
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.